(Q40182103)

18 September 2017

Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood (English)

1 reference

18 September 2017

4

1 reference

18 September 2017

Sarah E Furchert

1

1 reference

18 September 2017

Claudia Lanvers-Kaminsky

2

1 reference

18 September 2017

Heribert Juürgens

3

1 reference

18 September 2017

Adele Loidl

5

1 reference

18 September 2017

Michael C Frühwald

6

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

International Journal of Cancer

18 September 2017

1 reference

18 September 2017

120

1 reference

18 September 2017

1787-1794

1 reference

18 September 2017

8

1 reference

DNA methylation and histone modifications: teaming up to silence genes

18 September 2017

1 reference

Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential

21 January 2018

1 reference

DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

21 January 2018

1 reference

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies

21 January 2018

1 reference

The human histone deacetylase family

21 January 2018

1 reference

Chromatin modifications as targets for new anticancer drugs

21 January 2018

1 reference

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells

21 January 2018

1 reference

Valproic acid treatment of glioblastoma multiforme in a child

21 January 2018

1 reference

P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy

21 January 2018

1 reference

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

21 January 2018

1 reference

Subtype selective substrates for histone deacetylases

21 January 2018

1 reference

Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells.

21 January 2018

1 reference

Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines

21 January 2018

1 reference

Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood

21 January 2018

1 reference

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

21 January 2018

1 reference

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling

21 January 2018

1 reference

Histone deacetylase inhibitors--a new tool to treat cancer

21 January 2018

1 reference

The theoretical basis of transcriptional therapy of cancer: can it be put into practice?

21 January 2018

1 reference

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

Histone deacetylase is a target of valproic acid-mediated cellular differentiation

21 January 2018

1 reference

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma

21 January 2018

1 reference

Identification, mapping, and phylogenomic analysis of four new human members of the T-box gene family: EOMES, TBX6, TBX18, and TBX19

21 January 2018

1 reference

Clinical development of histone deacetylase inhibitors as anticancer agents

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.22401

1 reference

18 September 2017

1 reference